# SEATTLE CHILDREN'S HOSPITAL: The Role of Eosinophils in Immunotherapy-Related Adverse Events (irAEs)

**Lab Budget Score:** 55/100

| Field | Value |
|---|---|
| Organization | SEATTLE CHILDREN'S HOSPITAL |
| Location | SEATTLE, WA |
| Project | The Role of Eosinophils in Immunotherapy-Related Adverse Events (irAEs) |
| Project number | 1R01CA317772-01 |
| Mechanism | R01 |
| Institute | National Cancer Institute |
| Award | $793,012 |
| Awarded | 2026-09-17 |
| Project period | 2026-09-07 to 2031-08-31 |
| UEI | SZ32VTCXM799 |

## Why this score
- Award of $400K or more.
- Research or center grant: supplies, instruments and services budget.

Source: NIH RePORTER (newly awarded projects) (https://reporter.nih.gov/project-details/11432529). Last refreshed: 2026-11-03T18:16:24.961Z.
Award data comes from NIH RePORTER and may be revised by NIH. Organization-level only; investigator names and contacts are not included. Informational only.